Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression

Postnatal depression is an important problematic in French population with approximatively 10 -20% of women who suffer from postnatal depression. This pathology may have strong negative impact on both women and neonate's health.

The women's satisfaction degree in front of childbirth is an important factor associated with postnatal depression since women unsatisfied of their childbirth and/or women with a complicated childbirth are more encline to suffer from postnatal depression.

It is likely that the actual context of Covid 19 pandemia and the change in obstetrical cares organization may have a negative impact on women's satisfaction about their childbirth and so a negative impact on the risk of postnatal depression.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postnatal Depression Behavior COVID-19 Coronaviridae Infections Coronavirus Infections Depression, Postpartum Depressive Disorder Female Urogenital Diseases and Pregnancy Complications Infections Lung Diseases Mental Disorders Mood Disorders Nidovirales Infections Personal Satisfaction Pneumonia Pneumonia, Viral Pregnancy Complications Puerperal Disorders RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Urogenital Diseases Virus Diseases

Age range

18 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

Bertrand GACHON

Poitiers, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

women older than 18 years
women who deliver of a singleton, term neonate in cephalic presentation

Exclusion criteria

women younger than 18 years
women who deliver of a baby in non cephalic presentation
women with pre term Birth
women without any internet access
women with psychiatric disorders
women who do not understand french language
women who refuse to be aware of the results of the postnatal depression screening and who refuse that her doctor be ware of the results

Treatment and study plan

Assessment of postnatal depression using the the Edinburgh questionnaire between 4 and 6 weeks after delivery

Other

The Edinburgh questionnaire is a self questionnaire validated for postnatal depression between 4 and 6 weeks postnatal

Other names: Assessment of satisfaction about childbirth using the WOMBLSQ4 questionnaire within the week after delivery, Retrospective assessment of prenatal anxiety within the week after the delivery, Assessment of pelvic floor disorders using the PFDI questionnaire between 4 and 6 weeks after delivery, Assessment of self rated health for the woman and the child using the WHO question about self rated health between 4 and 6 weeks after delivery

Primary outcomes

Report postnatal depression between 4 of 6 weeks during the covid 19 pandemia

Time frame: 4-6 weeks postpartum

proportion of women with an Edinburgh score higher than 12 between 4 and 6 weeks postpartum

Secondary outcomes

Report factors associated with postnatal depression between 4 of 6 weeks during the covid 19 pandemia

Time frame: 4-6 weeks postpartum

Existence of an association with postnatal depression and these factors: socio demographic women's characteristics, modalities of pregnancy management, satisfaction and experience about delivery, postnatal pelvic floor disorders, self rated health for the woman and the child, modalities of delivery, prenatal anxiety
Describe the experience and the satisfaction about delivery during the covid 19 pandemia

Time frame: within the week after delivery

Scale from 0 to 10 of satisfaction ; answers to the WOMBLSQ4 questionnaire about childbirth experience and satisfaction

Sponsors and collaborators

Lead sponsor

Poitiers University Hospital

Other

Registry information

Acronym: DEPRECOVID

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Apr 29, 2020
Registry last updated: Jan 26, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed